Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4 , Pages 361-363, July 2008

Familial pheochromocytoma

  • Mary A. Bissada, M.D.

      Affiliations

    • Departments of Urology and Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
  • ,
  • Ahmed S. Safwat, M.D.

      Affiliations

    • Departments of Urology and Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
  • ,
  • Raouf M. Seyam, M.D.

      Affiliations

    • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • ,
  • Saif Al Sobhi, M.D.

      Affiliations

    • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • ,
  • Kamal A. Hanash, M.D.

      Affiliations

    • King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
  • ,
  • Nabil K. Bissada, M.D.

      Affiliations

    • Departments of Urology and Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-501-686-5241; fax: +1-501-686-5277.

Received 21 February 2007; received in revised form 22 March 2007; accepted 22 March 2007. published online 14 December 2007.

Abstract 

Objectives

To identify disease characteristics, operative outcome, and prognosis in patients with familial pheochromocytoma.

Methods

Records of 29 patients with familial pheochromocytoma were retrospectively analyzed. Patients' age, gender, presenting symptoms and clinical signs, chemical and radiologic findings, and associated conditions were recorded.

Results

Of the 29 patients, 25 were adults and 4 were children. Age ranged from 18 to 52 years (mean age 30.8 years). Twenty patients were females. Of the 29 patients, 26 had adrenal tumors, 2 had extra-adrenal tumors, and 1 had a combined adrenal and extra-adrenal tumor. The patients included 17 with multiple endocrine neoplasia (MEN), 8 with von Hippel Lindeau disease (vHLD), and 4 with Von Recklinghausen disease (vRD). Two patients had malignant pheochromocytoma. All except one patient with MEN had thyroid carcinoma. The two patients with malignant pheochromocytoma had MEN II. All patients were managed by either open or laparoscopic adrenalectomy or excision of extra-adrenal tumors. There was no perioperative mortality.

Conclusions

Associated conditions in patients with familial varieties are often the dominant or initial presentation. Presence of other manifestations of familial pheochromocytoma significantly influenced the clinical course and prognosis. However, it had no bearing on operative outcome of these patients.

Keywords: Adrenal, Pheochromocytoma, Hypertension, Multiple endocrine neoplasia, Neuroectodermal syndromes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(07)00088-9

doi:10.1016/j.urolonc.2007.03.025

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 4 , Pages 361-363, July 2008